The ADHD Child Care Guide, the Latest Free Report Available on Attention-Deficit Hyperactivity Disorder, Is Now Available at ADHDChildCare.com

Shire PLC said Tuesday that U.S. regulators approved its attention deficit hyperactivity disorder patch Daytrana for use in adolescents age 13 to 17.

Reportlinker.com announces that a new market research report is available in its catalogue:

Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD),[1] according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA� (OROS� methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children ...

Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA� (OROS� methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with ...